We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. Show more
Avidity Biosciences to Participate in Upcoming Investor Conference PR Newswire SAN DIEGO, Nov. 26, 2024 SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a...
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Nov. 21, 2024 SAN DIEGO, Nov. 21, 2024 /PRNewswire/ --Β Avidity Biosciences, Inc...
Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations PR...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.65 | -10.0302280846 | 36.39 | 36.6869 | 32.04 | 1424445 | 33.56683451 | CS |
4 | -10.08 | -23.5404016815 | 42.82 | 45.98 | 32.04 | 1138601 | 38.09336221 | CS |
12 | -11.26 | -25.5909090909 | 44 | 56 | 32.04 | 1095925 | 43.4859286 | CS |
26 | -6.39 | -16.3301814465 | 39.13 | 56 | 32.04 | 1343952 | 43.11253307 | CS |
52 | 24.01 | 275.028636884 | 8.73 | 56 | 8.37 | 1280187 | 33.22804062 | CS |
156 | 9.57 | 41.3034095814 | 23.17 | 56 | 4.825 | 1019771 | 22.15053976 | CS |
260 | 14.09 | 75.5495978552 | 18.65 | 56 | 4.825 | 763461 | 22.51456372 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions